【satka matka bombay】China sees continuous decline in hepatitis B incidence rate
BEIJING,satka matka bombay July 14 (Xinhua) -- China has seen declining incidence rates of hepatitis B and related hepatocellular carcinoma (HCC), according to Chinese health authorities.
China has achieved significant progress in increasing the rate of hepatitis B vaccination, containing new hepatitis B infections, and preventing and controlling HCC related to hepatitis B, said Li Bin, deputy head of the National Health Commission, at a conference on the matter on Saturday.
Data shows that China's three-dose hepatitis B vaccination rate among newborns has been maintained at over 95 percent and reached the 2030 goal set by the World Health Organization.
In 2022, around 367,700 new cases of liver cancer were reported in China, with a standardized incidence rate of approximately 15.03 per 100,000 people, revealing a downward trend when compared to historical data.
Zhuang Hui, academician of the Chinese Academy of Engineering, has called for continued efforts to improve hepatitis B diagnosis and treatment rates.
The key to eliminating hepatitis B and reducing its mortality rate is vaccinating susceptible adults that do not have immunity against the virus and other groups at risk, Zhuang suggested.
China still faces challenges as it works toward the goal of eliminating hepatitis B by 2030, Li said, adding that more will be done to promote vaccination and optimize testing strategies.
Editor: Zhang Zhou(责任编辑:知识)
- Cambodia inaugurates 37.5
- 单机游戏大合集:超好玩的中文版
- 主机版即将到来?《鸣潮》PS图标现身游戏文件目录
- 单机文字冒险游戏推荐
- China's energy transition: Developing new quality productive forces in energy sector
- 单机游戏中的经典文字冒险作品推荐
- 《重装前哨》全新预告片发布:7月30日上线!
- 三星扩大免费换屏计划 覆盖更多Galaxy S系列机型
- 唯有热爱可抵岁月漫长
- 苹果研发新科技 iPhone与AirPods实现群聊 不需要流量
- 单机文字游戏的热门角色扮演游戏推荐
- 博科YigoERP驱动央国企数字化转型新动力
- Xi demands all
- 单机游戏的创新与技术突破